• CanSinoBIO held its annual Scientific Advisory Board meeting at Vaccinopolis, University of Antwerp, Belgium, on October 15, 2026.
• Discussions focused on vaccine pipeline progress, global clinical development and regulatory strategies.
• Experts also examined emerging vaccine technologies to inform future product development and global market strategies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cansino Biologics Inc. published the original content used to generate this news brief on October 16, 2026, and is solely responsible for the information contained therein.